Rıdvan Ali
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Platelet Disorders and Treatments
- Microbiology top 10%
Papers in
- Hematology 36
- Chronic Myeloid Leukemia Treatments 12
- Acute Myeloid Leukemia Research 7
- Platelet Disorders and Treatments 6
- Multiple Myeloma Research and Treatments 5
- Genetics 12
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Fahir Özkalemkaş (47 shared papers)Vildan Özkocaman (44 shared papers)Ahmet Tunalı (26 shared papers)Tülay Özçelik (27 shared papers)Yalçın Kímya (8 shared papers)Massimo Terzolo (1 shared paper)Alberto Angeli (1 shared paper)Charlotte Suppli Ulrik (1 shared paper)
- Journals
- Leukemia Research (8 papers)Annals of Hematology (5 papers)Scientific Reports (2 papers)Annals of Clinical Microbiology and Antimicrobials (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- TürkiyeIranUnited States
In The Last Decade
Rıdvan Ali
107 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Hematology 442
- Microbiology 14
- Genetics 66
- Endocrinology, Diabetes and Metabolism 82
- Surgery 193
Countries citing papers authored by Rıdvan Ali
This map shows the geographic impact of Rıdvan Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rıdvan Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rıdvan Ali more than expected).
Fields of papers citing papers by Rıdvan Ali
This network shows the impact of papers produced by Rıdvan Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rıdvan Ali. The network helps show where Rıdvan Ali may publish in the future.
Co-authors
The 25 scholars most cited alongside Rıdvan Ali, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 171 | |
| 2 | 2010 | 132 | |
| 3 | 2012 | 89 | |
| 4 | 2008 | 60 | |
| 5 | 2004 | 54 | |
| 6 | 2005 | 46 | |
| 7 | 2011 | 46 | |
| 8 | 2003 | 34 | |
| 9 | Enucleation and evisceration: indications, complications and clinicopathological correlations | 2014 | 27 |
| 10 | 2009 | 25 | |
| 11 | 2013 | 25 | |
| 12 | Actinomycins and intrauterine contraceptive devices: the clinicopathologic study. | 1980 | 24 |
| 13 | Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status | 2008 | 23 |
| 14 | 2003 | 22 | |
| 15 | 2003 | 20 | |
| 16 | 2012 | 20 | |
| 17 | 2006 | 17 | |
| 18 | 2006 | 17 | |
| 19 | 2006 | 16 | |
| 20 | Crohn＇s disease complicated by multiple stenoses and interna fistulas clinically mimicking small bowel endometriosis | 2008 | 16 |
About Rıdvan Ali
Rıdvan Ali is a scholar working on Hematology, Genetics, Hepatology, Oncology and Infectious Diseases, having authored 121 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Acute Myeloid Leukemia Research (7 papers), Antifungal resistance and susceptibility (6 papers), Platelet Disorders and Treatments (6 papers), Pregnancy and Medication Impact (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). The work is most often cited by research in Hematology (442 citations), Microbiology (14 citations), Genetics (66 citations), Endocrinology, Diabetes and Metabolism (82 citations) and Surgery (193 citations). Rıdvan Ali has collaborated with scholars based in Türkiye, Iran and United States. Frequent co-authors include Fahir Özkalemkaş, Vildan Özkocaman, Ahmet Tunalı, Tülay Özçelik, Yalçın Kímya, Massimo Terzolo, Alberto Angeli, Charlotte Suppli Ulrik, Nilgün Köksal and Tahsin Yakut. Their work appears in journals such as Leukemia Research, Annals of Hematology, Scientific Reports, Annals of Clinical Microbiology and Antimicrobials and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.